FIELD: medicine.
SUBSTANCE: group of inventions refers to medicine and can be used for treating body system involvements caused by activated peroxidation. There is a liquid pharmaceutical composition offered therefore containing 2-ethyl-6-methyl-3-hydroxypyridine succinate, surface active substances and a sulphite stabiliser in a certain ratio. The composition is suggested to be introduced sublingually in the form of a spray.
EFFECT: composition is characterised by high storage stability and improved efficacy enabling an effect similar to such provided by an injection formulation, with a substantially smaller dose of an active agent.
9 cl, 6 tbl, 5 ex
